12 days ago
GILD
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 18%
#994 out of 5550 analysts
Average Return
+16.88%
Win Rate
59%19 out of 32
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Apogee Therapeutics IncAPGE | +268.54% | $36.62 | $134.96 | 2025-08-28 - 2026-08-27 | Strong Buy |
Metsera IncMTSR | +157.96% | $27.33 | $70.50 | 2025-02-25 - 2025-11-14 | Strong Buy |
Metsera IncMTSR | +101.20% | $35.04 | $70.50 | 2025-08-28 - 2025-11-14 | Strong Buy |
Merck & Co IncMRK | +49.13% | $100.26 | $149.52 | 2025-12-15 - 2026-10-30 | Strong Buy |
Gilead Sciences IncGILD | +43.27% | $105.96 | $151.81 | 2025-02-13 - 2026-02-12 | Strong Buy |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
4 months ago
BMY
a year ago
LLY
a year ago
MRK
a year ago
BMY
a year ago
PFE
a year ago
JNJ
2 years ago
JNJ
2 years ago
GILD
2 years ago
MRK
2 years ago
JNJ
2 years ago
JNJ
2 years ago
PFE
2 years ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gilead Sciences IncGILD | 4 | Strong Buy | $172.00 | +0.77% | Maintains | 12 days ago |
Amgen IncAMGN | 7 | Sell | $312.00 | -33.05% | Maintains | 4 months ago |
Johnson & JohnsonJNJ | 11 | Hold | $263.00 | -3.73% | Maintains | 4 months ago |
Bristol Myers Squibb CoBMY | 3 | Strong Buy | $66.00 | +5.63% | Maintains | 4 months ago |
Merck & Co IncMRK | 6 | Strong Buy | $141.00 | -5.70% | Maintains | 4 months ago |
Eli Lilly & CoLLY | 2 | Strong Buy | $1,268.00 | -10.55% | Maintains | a year ago |
Regeneron Pharmaceuticals IncREGN | 3 | Sell | $627.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 3 | Hold | $30.00 | N/A | Maintains | a year ago |
Apogee Therapeutics IncAPGE | 1 | Strong Buy | $87.00 | N/A | Maintains | a year ago |
Metsera IncMTSR | 2 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Aardvark Therapeutics IncAARD | 3 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Abbvie IncABBV | 7 | Hold | $204.00 | N/A | Maintains | 2 years ago |
Moderna IncMRNA | 2 | Sell | $34.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 1 | Hold | $178.00 | N/A | Reinstates | 2 years ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Astrazeneca PLCAZN | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.